Acutaas Chemicals DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.73×	0.74×	0.74×	0.59×	0.74×
	1.03×	1.09×	1.05×	0.73×	1.02×
	36.5%	33.2%	20.4%	15.7%	17.9%
	0.76×	0.76×	0.76×	0.77×	0.87×
	1.16×	1.16×	1.17×	1.61×	1.29×
	24.2%	23.5%	14.2%	8.4%	15.2%
	24.1%	24.1%	16.0%	6.8%	14.9%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ACUTAAS₹3,148.30

Acutaas Chemicals Ltd.

· Pharma & Health

₹ CrorePeersANURAS AETHER BLUEJET CAPLIPOINT CONCORDBIO EMCURE JBCHEPHARM ERISMcap ₹25,776 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.74	0.59	0.74	0.74	0.73
Interest Burden (Pretax/EBIT) ×	1.02	0.73	1.05	1.09	1.03
EBIT Margin %	17.88	15.67	20.40	33.18	36.50
Asset Turnover ×	0.87	0.77	0.76	0.76	0.76
Financial Leverage (Assets/Equity) ×	1.29	1.61	1.17	1.16	1.16
ROE (5-step product, year-end total equity) %	15.17	8.39	14.21	23.45	24.21
ROE (owners' profit / average owners' equity) %	14.92	6.75	16.00	24.05	24.05

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.